P.O. Box 50030 London, ON N6A 6H8 info@rett.ca (519) 474-6877

Health Canada Accepts a New Drug Submission 

Health Canada Accepts New Drug Submission for Trofinetide Acadia Pharmaceuticals is pleased to share that Health Canada has accepted their New Drug Submission (NDS) of trofinetide for the treatment of Rett Syndrome. Moreover, the treatment has been granted Priority Review to… Read More

19th Rett Classic Registration

Registration for the 19th Rett Classic closes Friday,, May 24, 2024